Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641

[Image: see text] Tuberculosis (TB) remains a major global health concern, and new therapies are needed to overcome the problems associated with dosing frequency, patient compliance, and drug resistance. To reduce side effects associated with systemic drug distribution and improve drug concentration...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Pharm
Asıl Yazarlar: D’Addio, Suzanne M., Reddy, Venkata M., Liu, Ying, Sinko, Patrick J., Einck, Leo, Prud’homme, Robert K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Chemical Society 2015
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4423248/
https://ncbi.nlm.nih.gov/pubmed/25811733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp5008663
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller